Navigation Links
approve in Biological Technology

Schering-Plough Shareholders Approve Merger With Merck

BOSTON, Aug. 7 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) announced the voting results of a special shareholders meeting today regarding the proposed merger with Merck & Co., Inc. More than 99 percent of votes cast voted to approve the merger agreement, wit...

TransTech Services Partners, Inc. Shareholders Approve Plan of Liquidation; Company To Distribute Amounts in Trust

NEW YORK, July 10 /PRNewswire-FirstCall/ -- TransTech Services Partners, Inc.("Company") (OTC Bulletin Board: TTSPU, TTSP, TTSPW) today announced that its stockholders voted at its special meeting held on July 8, 2009 to approve the plan of liquidation of the Company. The board of directors...

Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting

-Company's New Name is PROLOR Biotech, Inc.- -Will Now Trade under New Ticker PBTH- -Shareholders Approve Re-Election of Board of Directors and Other Proposals- NES-ZIONA, Israel, June 12 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG) today announced that shareho...

Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma

SAN CARLOS, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO ) today announced that the stockholders of Nuvelo have approved the issuance of Nuvelo Common Stock pursuant to the merger agreement dated September 24, 2008, as amended, between Nuvelo, ARCA biopharma and a Nuve...

Iomai Stockholders Approve Merger With Intercell Subsidiary

GAITHERSBURG, Md., Aug. 1 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI ) announced today that its stockholders approved the merger of Iomai with a wholly-owned subsidiary of Intercell AG. Approximately 71.6 percent of Iomai's outstanding shares entitled to vote at the special mee...

Shareholders Approve All Matters Proposed by Cell Therapeutics, Inc. at Special Meeting in Lieu of Annual Meeting of Shareholders

Proposals approved by more than 95 percent of votes cast SEATTLE, June 20 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC ; MTA) held a Special Meeting in lieu of the Annual Meeting of Shareholders on Thursday, June 19, 2008 at its headquarters in Seattle. At the...

Results of Court Meeting and Extraordinary General Meeting - Shareholders Approve Scheme of Arrangement and New Share Plans

BASINGSTOKE, England and PHILADELPHIA, May 9 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that ordinary shareholders approved the scheme of arrangement proposed in a circular to shareholders dated 16 April 2008 (the "C...

CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Company's Common Stock and Trading in Post-split Shares Begins May 9, 2008

Split Intended to Maintain Nasdaq Listing and Attract Additional Investors as Company Enters Next Growth Phase SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- CardioDynamics (Nasdaq: CDIC), the innovator and leader of BioZ(R) impedance cardiography (ICG) technology, today announced ...

Renovis Stockholders Approve Acquisition by Evotec

SOUTH SAN FRANCISCO, Calif., May 1 /PRNewswire-FirstCall/ -- Renovis, Inc. (Nasdaq: RNVS ) announced today that its stockholders approved the adoption of the merger agreement with Evotec AG (Frankfurt Stock Exchange: EVT) at a special meeting of stockholders held today. The merger is expected...

VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal

General Meeting vote suggests broad stockholder support for proposed Raven merger SOUTH SAN FRANCISCO, Calif., Dec. 27 /PRNewswire-FirstCall/ -- VaxGen Inc. (Pink Sheets: VXGN), a biopharmaceutical company, announced today that its stockholders approved the propo...

Biomira Shareholders Approve Move to U.S.

EDMONTON, Dec. 4 /PRNewswire-FirstCall/ - Biomira Inc. (Nasdaq: BIOM ) (TSX: BRA) ("Biomira", the "Company") today announced that the Company's shareholders have approved a plan of arrangement under which the Company will move to the United States and change its name to Oncothyreon Inc. ("Onc...

Nabi Biopharmaceuticals' Stockholders Approve Asset Sale

BOCA RATON, Fla., Nov. 8 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals (Nasdaq: NABI ) (the "Company") announced that, at today's Special Meeting of Stockholders, its stockholders voted overwhelmingly to approve the previously announced sale of assets transaction involving Biotest Pharmac...

Paramount Stockholders Approve Acquisition of Chem Rx

NEW YORK, Oct. 22 /PRNewswire-FirstCall/ -- Paramount Acquisition Corp. (OTC Bulletin Board: PMQC, PMQCU, PMQCW) ("Paramount") announced today that its stockholders have approved the acquisition of all of the issued and outstanding stock of B.J.K. Inc., a New York corporation doing business as...

Kyphon Stockholders Approve Merger with Medtronic

SUNNYVALE, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Kyphon Inc. (Nasdaq: KYPH ) announced today that its stockholders approved the adoption of the merger agreement with Medtronic, Inc. (NYSE: MDT ) at a special meeting of stockholders held today. As previously announced, on July 26, 2007, ...

Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction

PETACH TIKVA, Israel, August 16 /PRNewswire-FirstCall/ -- Healthcare Technologies Ltd. (NASDAQ: HCTL ), announced today that, it has scheduled an extraordinary general meeting of its shareholders to be held on September 30, 2007 at 11:00 a.m., at the offices of Yigal Arnon & Co., 1 Azrieli Ce...

Seven good reasons to approve the Institutes for Discovery

Ever since the Trojans hauled that giant wooden statue inside their walls, and woke up to the sound of armed Greeks in the streets, people have been examining gift horses carefully. There's generally nothing wrong with that careful policy - within reason. The state Building Commission will def...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...those of the Shionogi & Co., Ltd. Phase 3 trial of pirfenidone and there can be no assurance that the U.S. or European regulatory authorities will approve the use of pirfenidone for the treatment of IPF; (x) the results as reported by Shionogi concerning their Phase 3 trial may differ from those publishe...

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

... clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMEA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other ...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

...n) for the outpatient treatment of adults with mild-to-moderate community acquired pneumonia (CAP). In its letter, the FDA indicated that they cannot approve the application for Restanza in its current form and that, to gain approval, additional clinical data is required to demonstrate efficacy. Advanced Li...

TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction

.... The purpose of the meeting was for stockholder to vote upon a proposal to approve the liquidation and dissolution of TPTX. Given the recent entry in an Agre...lated to the merger; that stockholders of either TorreyPines or Raptor will approve the transaction by approving the respective items related to the merger as ...

U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International

...others, could cause actual results to differ materially from those described in the forward-looking statements: failure of HeartWare's stockholders to approve the proposed transaction; and other economic, business, competitive, and/or regulatory factors affecting the businesses of Thoratec and HeartWare gene...

Sanofi-aventis Announces Second Quarter 2009 Results

... clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMEA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labeling and other m...

Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S.

...in the Company's shares on a single market in the U.S. Shareholders will be asked to vote at the annual meeting or through proxies on a resolution to approve the de-listing. Further details will be announced in due course. The Company has sufficient cash at hand to fund operations into August, how...

NEW Momentum(TM) Physician and Staff Scheduling Software for Imaging Centers, OB/GYN, and Other Specialty Practices Improves Productivity and Equity in Scheduling

...rs, by real end-users. It is easy to use and is customized for each customer's scheduling approach and needs. Portals make it easy to enter, view, and approve requests. It saves weeks of time building schedules, leaving more time for patient care. "The software actually learns and evolves with each ...

Cadila Pharmaceuticals Launches Joint Venture With Novavax in India

...luenza vaccine or any other vaccine that we may develop; further testing is required before regulatory approval can be applied for and the FDA may not approve a vaccine even if further trial results are similar to those disclosed previously by the company; uncertainties relating to clinical trials; dependen...

Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Charter Amendments

...ll hold a special meeting of its stockholders on August 27, 2009. At the special meeting of stockholders, Cornerstone's stockholders will be asked to approve a series of amendments to Cornerstone's certificate of incorporation that if adopted will implement governance arrangements and provide Chiesi Farmace...

Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2009

...luenza vaccine or any other vaccine that we may develop; further testing is required before regulatory approval can be applied for and the FDA may not approve a vaccine even if further trial results are similar to those disclosed previously by the company; uncertainties relating to clinical trials , includ...

FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA(TM) for Refractory Chronic Gout

...our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to, the possibility that the FDA may not approve our BLA for KRYSTEXXA, notwithstanding the recommendation of the Advisory Committee; any delay or failure by us in completing the development of KRYST...

TechNet Urges Swift U.S. Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell

...lius Genachowski and Robert McDowell for seats on the Federal Communications Commission (FCC) and strongly urged the U.S. Senate Commerce Committee to approve their nominations. Mr. Genachowski has been nominated by President Obama for Chairman of the Commission and Mr. McDowell is being re-nominated for a ...

CardioDynamics Agrees to be Acquired by SonoSite for $1.35 Per Share

... the companies, including future financial and operating results, continued market acceptance of product offerings, the failure of our shareholders to approve the merger, the potential effects on our business as a result of the uncertainty regarding the merger, and the risk that the acquisition may not be c...

Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus

...luenza vaccine or any other vaccine that we may develop; further testing is required before regulatory approval can be applied for and the FDA may not approve a vaccine even if further trial results are similar to those disclosed previously by the company; uncertainties relating to clinical trials; dependenc...

ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema

...sfully treats acute hereditary angioedema attacks or that the FDA will ever approve Cinryze for the acute treatment of hereditary angioedema. In addition, there can be no assurance that the FDA will not approve a competing product which has been granted orphan drug designation thereby ...

TorreyPines Therapeutics Announces its Board of Directors' Approval of Plan of Liquidation and Dissolution

...uct candidates. The Plan of Dissolution contemplates an orderly wind down of the Company's business and operations. If the Company's stockholders approve the Plan of Dissolution, the Company intends to file a certificate of dissolution, satisfy or resolve its remaining liabilities and obligations, inclu...

The West Michigan Science & Technology Initiative is Named Statewide Reviewer for Life Science Funding Requests Through New Program

...ND RAPIDS, Mich., May 20 /PRNewswire/ -- The West Michigan Science & Technology Initiative today announced that it has been selected to review and approve applications from life science companies for micro-loans through the Michigan Pre-Seed Capital Fund. The Michigan Pre-Seed Capital Fund Micro Loan pr...

Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business

... Accordingly, at the annual general meeting of the shareholders to be held on June 9, 2009, the disinterested shareholders of Neptune will be asked to approve the Acasti Plan and the grant of 850,000 stock options to various Acasti directors, officers and employees made on October 8, 2008. (1) Earnings ...

ViroPharma Incorporated Honored by the National Organization for Rare Disorders

... delay any decision past the time frames anticipated by us, limit any approved indications, deny the approval of Cinryze for acute treatment of HAE or approve a competing product which has been granted orphan drug designation thereby preventing Cinryze from reaching the market for acute treatment of HAE. The...

Schering-Plough Schedules Webcast For Annual Meeting of Shareholders

...mp; Co., Inc., is not on the agenda for the Annual Meeting. However, shareholders of Schering-Plough and of Merck will have an opportunity to vote to approve the proposed combination at Special Meetings of Shareholders, anticipated to be held by each company later this year. Those wishing to listen liv...

Dendreon Reports First Quarter 2009 Financial Results

...e FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a biologics license has been applied, the risk that the results of a clinical trial for PROVENGE or other product may not be indic...

Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate

...luenza vaccine or any other vaccine that we may develop; further testing is required before regulatory approval can be applied for and the FDA may not approve a vaccine even if further trial results are similar to those disclosed previously by the company; uncertainties relating to clinical trials; dependen...

InterMune Reports First Quarter 2009 Financial Results and Business Highlights

...those of the Shionogi & Co., Ltd. Phase 3 trial of pirfenidone and there can be no assurance that the U.S. or European regulatory authorities will approve the use of pirfenidone for the treatment of IPF; (x) the results as reported by Shionogi concerning their Phase 3 trial may differ from those publishe...
Other Tags
(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
Other Contents